Leukemia & Lymphoma
Volume 63, 2022 - Issue 7
Open access
3,632
Views
7
CrossRef citations to date
0
Altmetric
Letters to Editor
Momelotinib reduces transfusion requirements in patients with myelofibrosis
Ruben Mesaa Mays Cancer Center, UT Health San Antonio Cancer Center, San Antonio, TX, USACorrespondence[email protected]
https://orcid.org/0000-0001-5880-7972View further author information
Stephen T. Ohb Department of Medicine, Washington University School of Medicine, St. Louis, MO, USAView further author information
, Aaron T. Gerdsc Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USAView further author information
, Vikas Guptad Department of Medicine, Princess Margaret Cancer Centre, Toronto, ON, CanadaView further author information
, John Catalanoe Haematology Department, Monash University & Frankston Hospital, Frankston, AustraliaView further author information
, Francisco Cervantesf Hematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, SpainView further author information
, Timothy Devosg Department of Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, BelgiumView further author information
, Marek Hush Hematooncology Department, Medical University of Lublin, Lublin, PolandView further author information
, Jean-Jacques Kiladjiani Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d’Investigations Cliniques, INSERM, Paris, FranceView further author information
, Ewa Lech-Marandaj Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, PolandView further author information
, Donal McLornank Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UKView further author information
, Jeanne Palmerl Division of Hematology and Medical Oncology, Mayo Clinic Hospital, Phoenix, AZ, USAView further author information
, Uwe Platzbeckerm Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, GermanyView further author information
, Jacek Trelińskin Department of Hematology, Medical University of Lodz, Lodz, PolandView further author information
, Kazuya Shimodao Department of Internal Medicine, University of Miyazaki, Miyazaki, JapanView further author information
, Rafe Donahuep Biometrics, Sierra Oncology Inc, San Mateo, CA, USAView further author information
, Koenraad D’Hollanderq Biostatistics, International Drug Development Institute, Louvain-la-Neuve, BelgiumView further author information
, Mark Kowalskir Research and Early Development, Sierra Oncology Inc, San Mateo, CA, USAView further author information
& Srdan Verstovseks Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
show all
Pages 1718-1722
|
Received 30 Nov 2021, Accepted 05 Feb 2022, Published online: 07 Mar 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.